Toggle light / dark theme
https://pixabay.com/images/id-736885/ by Bessi

The leadership challenge for all commercial organisations today is one of delivering continuous growth to their shareholders while trying to navigate an increasingly uncertain future and a world being transformed by dramatic advances in science and technology. There is also an underlying sense that we have to do everything faster – perhaps for fear that the opportunities may not last very long. In response, we are seeing the growing use of two key growth strategies — the quest for exponential growth and the growing use of corporate venturing. I discussed exponential growth in Part 1, and in Part 2 I focus on the learning and development implications of the adoption of corporate venturing.

Corporate venturing and intrapreneuring are seen as ways of buying ourselves faster learning and growth. As organisations wrestle with finding the right path to the future, we can expect a growing focus on the use of corporate venturing, or corporate venture capital. This is basically the investment of funds in external start-up companies. Intrapreneuring tends to be used to refer to investment in new venture ideas generated by internal team members. Typically, these venturing approaches are focused on capital and resource investments in firms and internally generated ideas that could enhance the core business, create enterprises in adjacent sectors, or generate ventures that could potentially disrupt and compete with the existing entity.

This business model may become increasingly popular as firms look to these startups to help speed up knowledge acquisition, learn about emerging technologies, accelerate entry to new markets, or access critical skills and resources. Core to the success of such models are intrapreneurs and venture managers who can help the ventures gain the support they need from the core business without the imposition of unnecessary central processes and controls. Alongside these venture management skills, success requires internal leaders and functional heads to have the ability to collaborate with new ventures which might threaten their existing business.

As

Americans today spend more on pharmaceuticals per capita than anyone else in the world, and more than one in five say they have trouble affording their prescription drugs. But they might not know about the alternative pathways to medicine. VICE’s Hamilton Morris explores the world of clandestine chemists, DIY bio hackers, and grey markets to see if a more democratized medicinal future is indeed possible.

Check out VICE News for more: http://vicenews.com

Follow VICE News here:
Facebook: https://www.facebook.com/vicenews
Twitter: https://twitter.com/vicenews
Tumblr: http://vicenews.tumblr.com/
Instagram: http://instagram.com/vicenews
More videos from the VICE network: https://www.fb.com/vicevideo

#VICEonHBO